Alimera Sciences Inc (ALIM)
3.57
+0.03
(+0.85%)
USD |
NASDAQ |
Apr 23, 16:00
Alimera Sciences Gross Profit Margin (Quarterly): 86.22% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 86.22% |
| September 30, 2023 | 88.20% |
| June 30, 2023 | 86.17% |
| March 31, 2023 | 85.03% |
| December 31, 2022 | 84.85% |
| September 30, 2022 | 85.25% |
| June 30, 2022 | 85.17% |
| March 31, 2022 | 85.88% |
| December 31, 2021 | 85.92% |
| September 30, 2021 | 86.10% |
| June 30, 2021 | 91.65% |
| March 31, 2021 | 86.07% |
| December 31, 2020 | 85.54% |
| September 30, 2020 | 87.68% |
| June 30, 2020 | 85.21% |
| March 31, 2020 | 86.74% |
| December 31, 2019 | 86.90% |
| September 30, 2019 | 87.71% |
| June 30, 2019 | 89.18% |
| March 31, 2019 | 87.59% |
| December 31, 2018 | 91.23% |
| September 30, 2018 | 91.34% |
| Date | Value |
|---|---|
| June 30, 2018 | 91.48% |
| March 31, 2018 | 88.54% |
| December 31, 2017 | 88.59% |
| September 30, 2017 | 89.38% |
| June 30, 2017 | 92.58% |
| March 31, 2017 | 91.13% |
| December 31, 2016 | 91.35% |
| September 30, 2016 | 94.14% |
| June 30, 2016 | 94.18% |
| March 31, 2016 | 93.48% |
| December 31, 2015 | 91.95% |
| September 30, 2015 | 90.81% |
| June 30, 2015 | 93.49% |
| March 31, 2015 | 92.81% |
| December 31, 2014 | 92.53% |
| September 30, 2014 | 84.55% |
| June 30, 2014 | 82.83% |
| March 31, 2014 | 72.94% |
| December 31, 2013 | -91.98% |
| September 30, 2013 | 92.48% |
| June 30, 2013 | 93.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
84.85%
Minimum
Dec 2022
91.65%
Maximum
Jun 2021
86.60%
Average
86.10%
Median
Sep 2021
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 80.88% |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -99.16% |
| Return on Assets | -18.19% |
| Return on Invested Capital | -26.33% |
| Profit Margin (Quarterly) | -14.37% |
| Operating Margin (Quarterly) | 2.75% |
| Return on Net Operating Assets | -21.10% |